Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,645 | 36,145 | 59,406 | 72,637 | 74,888 |
| Marketable Securities | 44,186 | 0 | 26,260 | 32,888 | 74,311 |
| Receivables | N/A | N/A | N/A | 12 | 246 |
| TOTAL | $176,246 | $39,588 | $89,084 | $108,747 | $152,334 |
| Non-Current Assets | |||||
| PPE Net | 939 | 1,123 | 1,401 | 1,370 | 807 |
| Investments And Advances | 44,183 | 0 | 0 | 0 | 997 |
| Intangibles | 7,012 | 7,041 | 7,070 | 7,099 | 7,141 |
| Other Non-Current Assets | 3,606 | 4,963 | 5,030 | 5,152 | 5,426 |
| TOTAL | $55,739 | $13,127 | $13,501 | $13,621 | $14,371 |
| Total Assets | $231,985 | $52,714 | $102,585 | $122,367 | $166,705 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,543 | 1,959 | 2,112 | 3,155 | 1,394 |
| Accrued Expenses | 7,842 | 4,973 | 5,174 | 4,501 | 3,965 |
| Other current liabilities | 292 | 234 | 260 | 20 | 0 |
| TOTAL | $10,074 | $7,504 | $7,846 | $8,054 | $5,634 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,427 | 3,824 | 4,163 | 4,463 | 5,091 |
| TOTAL | $3,427 | $3,824 | $4,163 | $4,463 | $5,091 |
| Total Liabilities | $13,501 | $11,328 | $12,008 | $12,517 | $10,725 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,653 | 35,887 | 29,283 | 26,436 | 26,377 |
| Common Shares | 65 | 31 | 29 | 26 | 26 |
| Retained earnings | -280,320 | -224,295 | -163,259 | -109,787 | -59,273 |
| Other shareholders' equity | 81 | 0 | -1 | -30 | -49 |
| TOTAL | $218,484 | $41,386 | $90,576 | $109,850 | $155,980 |
| Total Liabilities And Equity | $231,985 | $52,714 | $102,585 | $122,367 | $166,705 |